Literature DB >> 33460013

Atypical anti-glomerular basement membrane disease complicated by methicillin-susceptible Staphylococcus aureus infection-related rapidly progressive glomerulonephritis: a case report and literature review.

Tomohisa Yamashita1, Komei Sato2, Keitaro Nishizawa2, Yuka Matsuhisa2, Hironori Kobayashi2.   

Abstract

Atypical anti-glomerular basement membrane (GBM) disease, which is characterized by low levels of or negativity for anti-GBM antibodies in circulation but positivity in the kidney, has been recognized in this decade. However, a therapeutic strategy has not been established to date because its outcome is better than that of classic anti-GBM disease. This case report and literature review highlight atypical anti-GBM disease in infection-related rapidly progressive glomerulonephritis. A 72-year-old Japanese man diagnosed with methicillin-susceptible Staphylococcus aureus (MSSA)-induced vertebral osteomyelitis experienced for 2 months was referred to our hospital because of renal insufficiency. He developed rapidly progressive glomerulonephritis with a serum creatinine level of 6.8 mg/dL, C-reactive protein level of 9.7 mg/dL, urinary protein-to-creatinine ratio of 3.37 g/gCr, and gross hematuria. The serum anti-GBM antibody concentration was 3.5 U/mL, which was slightly above the normal range (< 3.0 U/mL). Conservative treatment, mainly with antibiotics, improved the symptoms and renal function. The serum anti-GBM antibody concentration peaked at 4.0 U/mL on day 7 and decreased to an undetectable range at the end of eight-week antibiotic therapy. This is the first case report describing the presentation and disappearance of serum anti-GBM antibody in a patient with MSSA infection. Conservative treatment may be effective for patients with atypical anti-GBM disease complicated by infectious diseases.
© 2021. Japanese Society of Nephrology.

Entities:  

Keywords:  Anti-glomerular basement membrane disease; Rapidly progressive glomerulonephritis; Staphylococcus aureus

Year:  2021        PMID: 33460013     DOI: 10.1007/s13730-020-00564-9

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  1 in total

1.  Anti-GBM disease: predictive value of clinical, histological and serological data.

Authors:  M Herody; G Bobrie; C Gouarin; J P Grünfeld; L H Noel
Journal:  Clin Nephrol       Date:  1993-11       Impact factor: 0.975

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.